GLPBio

Lipids

Research Areas

Products Related to Lipids(470)

  • GC40975 structure
    GC4097517(S)-HpDHA
    CAS: 123673-33-6
    Purity: >98.00%

    17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.

  • GC40978 structure
    GC409787-epi Maresin 1
    CAS: 1268720-66-6
    Purity: >95.00%

    7-epi Maresin 1 is the inactive 7(S) epimer of Maresin 1, which contains a 7(R) hydroxyl group.

  • GC40980 structure
    GC40980Maresin 2
    CAS: 1639809-46-3
    Purity: ≥95.00%

    Maresin 2 ist ein entzÜndungshemmender und auflÖsungsfÖrdernder Mediator aus menschlichen Makrophagen.

  • GC40981 structure
    GC40981Protectin D1
    CAS: 660430-03-5
    Purity: >98.00%

    Protectin D1, Neuroprotectin D1, wenn es von neuralen Zellen erzeugt wird, ist ein Mitglied einer neuen Familie bioaktiver Produkte, die aus DocosahexaensÄure erzeugt werden.

  • GC40982 structure
    GC40982Resolvin D5
    CAS: 578008-43-2
    Purity: >95.00%

    Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.

  • GC41130 structure
    GC411305(S),6(R)-DiHETE MaxSpec® Standard
    CAS: 82948-88-7
    Purity: >98.00%

    5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4).

  • GC41134 structure
    GC411346-trans Leukotriene B4
    CAS: 71652-82-9
    Purity: >97.00%

    6-trans-Leukotrien B4 ist ein neutrophiles Chemotaxin in der Dermis von Meerschweinchen.

  • GC41135 structure
    GC411356-trans-12-epi Leukotriene B4
    CAS: 71548-19-1
    Purity: >97.00%

    6-trans-12-epi Leukotrien B4, ein Arachidonsäure-Metabolit, ist ein starkes entzündungshemmendes Mittel.

  • GC41146 structure
    GC41146FOG9
    Purity: >98.00%

    FOG9 is formed through the conjugation of 5-oxoETE with glutathione in a 1,6 Michael addition at C-9.

  • GC41188 structure
    GC411883-oxo Stearic Acid
    CAS: 16694-29-4
    Purity: >90.00%

    3-Oxo-StearinsÄure (3-OxostearinsÄure) ist eine gesÄttigte FettsÄure (SFA).

  • GC41191 structure
    GC41191(±)13(14)-EpDPA
    CAS: 895127-64-7
    Purity: >95.00%

    (±)13(14)-EpDPA (13,14-EpDPE) ist das Produkt der Reaktion von Cytochrom-P-450-Epoxygenase mit Docosahexaensäure (DHA).

  • GC41192 structure
    GC41192(±)13-HDHA
    CAS: 90780-53-3
    Purity: >98.00%

    (±)13-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

  • GC41193 structure
    GC41193(±)14-HDHA
    CAS: 87042-40-8
    Purity: >98.00%

    (±)14-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

  • GC41194 structure
    GC41194(±)16(17)-EpDPA
    CAS: 155073-46-4
    Purity: >90.00%

    EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.

  • GC41195 structure
    GC41195(±)16(17)-EpDPA MaxSpec® Standard
    CAS: 155073-46-4
    Purity: 90.00%

    EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.

  • GC41196 structure
    GC41196(±)16-HDHA
    CAS: 90780-51-1
    Purity: >98.00%

    (±)16-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

  • GC41197 structure
    GC41197(±)17-HDHA
    CAS: 90780-52-2
    Purity: >98.00%

    (±)17-HDHA is an autoxidation product of docosahexaenoic acid in vitro.

  • GC41198 structure
    GC41198(±)17-HDHA MaxSpec® Standard
    CAS: 90780-52-2
    Purity: >98.00%

    (±)17-HDHA is an autoxidation product of docosahexaenoic acid in vitro.

  • GC41199 structure
    GC41199(±)19(20)-EpDPA
    Purity: >98.00%

    EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.

  • GC41201 structure
    GC41201(±)4(5)-DiHDPA lactone
    CAS: 845673-68-9
    Purity: >95.00%

    (±)5(6)-DiHET lactone is a 1,5 cyclic ester derived from (±)5(6)-DiHET, which, in turn, is a potential derivative of epoxidation of arachidonic acid at the α-5 double bond.

  • GC41202 structure
    GC41202(±)4-HDHA
    CAS: 90906-40-4
    Purity: >95.00%

    (±)4-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

  • GC41203 structure
    GC41203(±)7(8)-EpDPA
    CAS: 895127-66-9
    Purity: >95.00%

    Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina.

  • GC41204 structure
    GC41204(±)7-HDHA
    CAS: 90780-55-5
    Purity: >98.00%

    (±)7-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.

  • GC41205 structure
    GC41205(±)8-HDHA
    CAS: 90780-54-4
    Purity: >98.00%

    (±)8-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.